Who owns Mineralys Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MLYS from SEC Form 13F filings across 226 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 226 institutions disclosed 99.7M shares of Mineralys Therapeutics, Inc. worth $2.69B — about 117.6% of shares outstanding; the largest disclosed holder is Catalys Pacific, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
226
13F holders
$2.69B
value, 2026 filers
117.6%
of shares outstanding (99.7M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MLYS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.9M | $213.2M | 92.9% | 9.3% | 0.0% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 7.7M | $207.6M | 1.8% | 9.1% | 0.0% |
| 3 | BlackRock, Inc. | 5.9M | $158.8M | 0.0% | 6.9% | +31.4% |
| 4 | SAMSARA BIOCAPITAL, LLC | 5.9M | $158.4M | 13.0% | 6.9% | 0.0% |
| 5 | FMR LLC | 4.5M | $121.7M | 0.0% | 5.3% | -7.2% |
| 6 | STATE STREET CORP | 4.1M | $111.7M | 0.0% | 4.9% | +41.1% |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P.NEW | 4.0M | $106.8M | 1.1% | 4.7% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | $74.4M | 0.0% | 3.3% | +12.3% |
| 9 | Laurion Capital Management LP | 2.5M | $67.6M | 1.7% | 3% | +12.3% |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.3M | $61.0M | 0.0% | 2.7% | +68.4% |
| 11 | ORBIMED ADVISORS LLC | 2.1M | $56.9M | 1.1% | 2.5% | +2.8% |
| 12 | Capital World Investors | 2.0M | $53.9M | 0.0% | 2.4% | +401.7% |
| 13 | ARMISTICE CAPITAL, LLC | 1.7M | $46.8M | 0.6% | 2% | +47.6% |
| 14 | Troluce Capital Advisors LLC | 1.7M | $46.6M | 4.8% | 2% | +163.9% |
| 15 | FRANKLIN RESOURCES INC | 1.6M | $44.1M | 0.0% | 1.9% | -8.4% |
| 16 | ANDERA PARTNERS | 1.6M | $42.9M | 20.8% | 1.9% | 0.0% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $42.8M | 0.0% | 1.9% | +21.8% |
| 18 | SR One Capital Management, LP | 1.6M | $42.2M | 4.1% | 1.8% | 0.0% |
| 19 | BANK OF AMERICA CORP /DE/ | 1.5M | $40.6M | 0.0% | 1.8% | +36.8% |
| 20 | SPHERA FUNDS MANAGEMENT LTD. | 1.5M | $39.7M | 5.2% | 1.7% | +9.7% |
| 21 | GOLDMAN SACHS GROUP INC | 1.5M | $39.4M | 0.0% | 1.7% | +85.8% |
| 22 | Pictet Asset Management Holding SA | 1.4M | $38.6M | 0.0% | 1.7% | +38.3% |
| 23 | Polar Capital Holdings Plc | 1.4M | $38.3M | 0.1% | 1.7% | -5.3% |
| 24 | MILLENNIUM MANAGEMENT LLC | 1.2M | $33.0M | 0.0% | 1.4% | +132.6% |
| 25 | Ghisallo Capital Management LLCNEW | 1.1M | $30.4M | 0.6% | 1.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.